# Arcturus Therapeutics Holdings Inc.: Form DEF 14A, filed May 2, 2022

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: DEF 14A
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 17:20 ET
- Period: 2022-06-21
- Accession: 0001193805-22-000731
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380522000731/e621607_def14a-arct.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380522000731/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380522000731/e621607_def14a-arct.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001193805-22-000731. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
